Cash Flow from Operation (CFO) to Debt Ratio Analysis of Immuneering Corp - Deep Dive
Cash Flow from Operation (CFO) to Debt Ratio of IMRX
Dec-23-0.163Very Poor CFO to Debt | Dec-22-116.45Very Poor CFO to Debt | Growth99.86% |
CFO to Debt Analysis of Immuneering Corp
Cashflow to Debt Ratio of Immuneering Corp with value of -0.163 shows the company has low cash flow to pay off their debts. |
CFO to Debt of IMRX rose handsomely by 99.86 % this year. |
CFO to Debt with value of 0 was highest in Year Dec-19 in last Five Years. |
CFO to Debt with value of -191.57 was lowest in Year Dec-20 in last Five Years. |
Latest CFO to Debt with value of -0.163 is Greater than Average CFO to Debt of -84.15 in last five years. |
Other CFO to Debt Related Info of IMRX that may interest you.
Immuneering Corp Overview
Code | Price | Previous Price | Price Change | Sector |
---|---|---|---|---|
IMRX | 1.39 | 1.38 | 0.725 % | Biotechnology |
Defination of Cash Flow from Operation (CFO) to Debt Ratio
Cash Flow from Operation (CFO) to Debt Ratio indicates how much time it will take for the company to meet its debt obligations by its cash flow from operations. more ..CFO to Debt Related Ratios
DebtToEBITDA | ShortTermDebtToEquityRatio | PriceToCashFlowRatio |
Tsr Stability Index
Mild Stability |
FY - Historical Cash Flow from Operation (CFO) to Debt Ratio of Immuneering Corp
Period | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 |
---|---|---|---|---|---|
CFO to Debt | -0.163 | -116.45 | -112.58 | -191.57 | 0 |
Change | 99.86 % | -3.44 % | 41.23 % |
FY Chart of Cash Flow from Operation (CFO) to Debt Ratio of Immuneering Corp
Note : All Data Generated at the End of Trading Hours (EOD Data)